Secretion inhibitor albumen is for the application of compartment syndrome between treatment

Secretion inhibitor albumen is for the application of compartment syndrome between treatment

  • CN 101,437,533 B
  • Filed: 04/27/2007
  • Issued: 10/12/2016
  • Est. Priority Date: 04/27/2006
  • Status: Active Grant
First Claim
Patent Images

1. the secretion inhibitor albumen corresponding to aminoacid VCHSKTRSNPENNVGL is manufacturing for treatment and/or is preventing a roomApplication in the pharmaceutical compositions of syndrome and/or medical food, wherein said compartment syndrome is to be felt by HSV-1 and/or SADye causes;

  • By urogenital tissues, body of gland, muscle, liquid capsule, nerve, blood vessel, joint and/or the abnormal load of tendon,Damage and/or disease cause;

    By the overload in intracranial, brain, in spinal column and/or spinal cord, damage and/or hemorrhage cause;

    OriginFrom in aneurysm, apoplexy and/or ischemic overload, damage and/or hemorrhage cause;

    By skin, heart, kidney, testis,The tamponade of ovary and/or lymphatic organ causes;

    Caused by internal optimum and/or malignant tumor, and/or wherein said syndrome pairOne or more intervertebral disc cause damage.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×